Carisma Therapeutics Is A Clinical Stage Biopharmaceutical Company Based In Philadelphiapennsylvaniathe Company Specializes In Developing Innovative Cellular Therapies That Utilize Monocytes And Macrophages To Address Serious Disordersincluding Cancerfibrosisand Autoimmune Diseasescarisma Operates In The Usthe Ukand Canada The Company Focuses On Engineered Therapies Such As Car Macrophages And Car Monocyteswhich Are Designed To Target Solid Tumors By Harnessing A Patient S Own Immune Cellskey Products In Their Pipeline Include Ct 1119Aimed At Oncologyand Ct 2401Which Targets Liver Fibrosiscarisma Is Also Developing Therapies For Autoimmune Diseasesthe Company Is Exploring Strategic Alternatives To Advance Its Programs And Has A Partnership With Moderna That May Lead To Future Milestone And Royalty Payments
